Read More Analyst Ratings News Price Target Piper Sandler Maintains Overweight on Magnolia Oil & Gas, Lowers Price Target to $32 By Benzinga Newsdesk October 18, 6:57 AM Piper Sandler analyst Mark Lear maintains Magnolia Oil & Gas (NYSE:MGY) with a Overweight and lowers the price target from $33 to $32. MGY
Read More Analyst Color Analyst Ratings Earnings General Guidance Health Care Large Cap Movers News Charles River Laboratories Stock Surges On Upbeat Annual Outlook, But This Analyst Is Concerned By Vandana Singh February 14, 2:40 PM Charles River Laboratories Q4 2023 revenue: $1.01 billion, down 7.9% YoY, beating consensus. Analysts note mixed Q4 performance, keeping Outperform rating. CRL
Read More Analyst Ratings News Price Target Goldman Sachs Maintains Buy on Pool, Lowers Price Target to $360 By Benzinga Newsdesk October 21, 8:31 AM Goldman Sachs analyst Susan Maklari maintains Pool (NASDAQ:POOL) with a Buy and lowers the price target from $410 to $360. POOL
Read More Biotech Events General News Horizon Therapeutics Plc Announces New UPLIZNA Data In Neuromyelitis Optica Spectrum Disorder To Be presented At ECTRIMS 2023 By Benzinga Newsdesk October 2, 8:14 AM -- Presentations will feature data from the pivotal Phase 3 study of UPLIZNA, including new biomarker analyses --Horizon Therapeutics plc (NASDAQ:HZNP) today announced that new UPLIZNA analyses will be presented at the HZNP